Minerva Neurosciences (NERV) Shares Issued (2013 - 2026)
Minerva Neurosciences (NERV) posted Shares Issued of $5.0 million for Q1 2026, down 38.28% on a QoQ basis from $8.2 million in Q4 2025, and up 239.41% year-over-year from $1.5 million in Q1 2025.
Minerva Neurosciences (NERV) Shares Issued (2013 - 2026) Analysis & Trends
Minerva Neurosciences' Shares Issued history runs 14 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- Quarterly Shares Issued rose 239.41% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 239.41% YoY) and the FY2025 annual result came in at $8.2 million, up 449.58% from the prior year.
- Shares Issued was $5.0 million for Q1 2026 at Minerva Neurosciences, down from $8.2 million in the prior quarter.
- Across five years, Shares Issued topped out at $8.2 million in Q4 2025 and bottomed at $174471.0 in Q3 2022.
- A 5-year average of $1.5 million and a median of $700929.0 in 2022 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2022 — Shares Issued sank 96.34% — and 2025, when it surged 449.58%.
- Minerva Neurosciences' Shares Issued stood at $700929.0 in 2022, then jumped by 65.1% to $1.2 million in 2023, then rose by 28.52% to $1.5 million in 2024, then jumped by 449.58% to $8.2 million in 2025, then slumped by 38.28% to $5.0 million in 2026.
- Business Quant data shows NERV's Shares Issued at $5.0 million in Q1 2026, $8.2 million in Q4 2025, and $228213.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 19.44 Mn |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - | 5.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.04 Mn |
| Mar 31, 2026 | 5.04 Mn |
| Dec 31, 2025 | 8.17 Mn |
| Dec 31, 2025 | 8.17 Mn |
| Sep 30, 2025 | 228,213.00 |
| Sep 30, 2025 | 228,213.00 |
| Jun 30, 2025 | 228,213.00 |
| Jun 30, 2025 | 228,213.00 |
| Mar 31, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 477,643.00 |
| Sep 30, 2024 | 477,643.00 |
| Jun 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Dec 31, 2023 | 1.16 Mn |